nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosinopril—ACE—forelimb zeugopod—peripheral nervous system neoplasm	0.0262	0.379	CbGeAlD
Fosinopril—ACE—forelimb—peripheral nervous system neoplasm	0.0132	0.19	CbGeAlD
Fosinopril—ACE—arm—peripheral nervous system neoplasm	0.0113	0.164	CbGeAlD
Fosinopril—ACE—nerve—peripheral nervous system neoplasm	0.00722	0.104	CbGeAlD
Fosinopril—ACE—ganglion—peripheral nervous system neoplasm	0.00713	0.103	CbGeAlD
Fosinopril—Ramipril—BCHE—peripheral nervous system neoplasm	0.00546	0.475	CrCbGaD
Fosinopril—SLC15A2—parotid gland—peripheral nervous system neoplasm	0.00288	0.0415	CbGeAlD
Fosinopril—Cilazapril—ABCB1—peripheral nervous system neoplasm	0.00221	0.192	CrCbGaD
Fosinopril—Lisinopril—ABCB1—peripheral nervous system neoplasm	0.00221	0.192	CrCbGaD
Fosinopril—Enalapril—ABCB1—peripheral nervous system neoplasm	0.00162	0.141	CrCbGaD
Fosinopril—SLC15A2—cerebellum—peripheral nervous system neoplasm	0.00133	0.0192	CbGeAlD
Fosinopril—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000407	CcSEcCtD
Fosinopril—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000405	CcSEcCtD
Fosinopril—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000372	0.000404	CcSEcCtD
Fosinopril—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000404	CcSEcCtD
Fosinopril—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000403	CcSEcCtD
Fosinopril—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000403	CcSEcCtD
Fosinopril—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000402	CcSEcCtD
Fosinopril—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000399	CcSEcCtD
Fosinopril—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000367	0.000399	CcSEcCtD
Fosinopril—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000398	CcSEcCtD
Fosinopril—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000365	0.000397	CcSEcCtD
Fosinopril—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000395	CcSEcCtD
Fosinopril—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.000395	CcSEcCtD
Fosinopril—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000392	CcSEcCtD
Fosinopril—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000359	0.000391	CcSEcCtD
Fosinopril—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000391	CcSEcCtD
Fosinopril—Pain—Cisplatin—peripheral nervous system neoplasm	0.000359	0.00039	CcSEcCtD
Fosinopril—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000389	CcSEcCtD
Fosinopril—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000354	0.000386	CcSEcCtD
Fosinopril—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.000384	CcSEcCtD
Fosinopril—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000353	0.000384	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000383	CcSEcCtD
Fosinopril—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000382	CcSEcCtD
Fosinopril—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000382	CcSEcCtD
Fosinopril—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000382	CcSEcCtD
Fosinopril—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.00035	0.000381	CcSEcCtD
Fosinopril—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00035	0.00038	CcSEcCtD
Fosinopril—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.000379	CcSEcCtD
Fosinopril—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000378	CcSEcCtD
Fosinopril—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000376	CcSEcCtD
Fosinopril—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000376	CcSEcCtD
Fosinopril—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000345	0.000376	CcSEcCtD
Fosinopril—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000375	CcSEcCtD
Fosinopril—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000374	CcSEcCtD
Fosinopril—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000373	CcSEcCtD
Fosinopril—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000343	0.000373	CcSEcCtD
Fosinopril—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000342	0.000372	CcSEcCtD
Fosinopril—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000342	0.000372	CcSEcCtD
Fosinopril—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000341	0.00037	CcSEcCtD
Fosinopril—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00034	0.00037	CcSEcCtD
Fosinopril—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000368	CcSEcCtD
Fosinopril—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.000367	CcSEcCtD
Fosinopril—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.000367	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000364	CcSEcCtD
Fosinopril—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.000364	CcSEcCtD
Fosinopril—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000334	0.000364	CcSEcCtD
Fosinopril—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000362	CcSEcCtD
Fosinopril—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000361	CcSEcCtD
Fosinopril—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000332	0.000361	CcSEcCtD
Fosinopril—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000332	0.000361	CcSEcCtD
Fosinopril—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000331	0.00036	CcSEcCtD
Fosinopril—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000358	CcSEcCtD
Fosinopril—Pain—Etoposide—peripheral nervous system neoplasm	0.000329	0.000358	CcSEcCtD
Fosinopril—Constipation—Etoposide—peripheral nervous system neoplasm	0.000329	0.000358	CcSEcCtD
Fosinopril—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000357	CcSEcCtD
Fosinopril—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000355	CcSEcCtD
Fosinopril—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.000354	CcSEcCtD
Fosinopril—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000325	0.000353	CcSEcCtD
Fosinopril—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000352	CcSEcCtD
Fosinopril—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000348	CcSEcCtD
Fosinopril—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000347	CcSEcCtD
Fosinopril—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000347	CcSEcCtD
Fosinopril—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000345	CcSEcCtD
Fosinopril—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000345	CcSEcCtD
Fosinopril—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000317	0.000345	CcSEcCtD
Fosinopril—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000316	0.000343	CcSEcCtD
Fosinopril—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000343	CcSEcCtD
Fosinopril—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000342	CcSEcCtD
Fosinopril—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000314	0.000342	CcSEcCtD
Fosinopril—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000314	0.000341	CcSEcCtD
Fosinopril—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000341	CcSEcCtD
Fosinopril—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00034	CcSEcCtD
Fosinopril—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000338	CcSEcCtD
Fosinopril—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.000338	CcSEcCtD
Fosinopril—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000337	CcSEcCtD
Fosinopril—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000309	0.000336	CcSEcCtD
Fosinopril—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000336	CcSEcCtD
Fosinopril—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000336	CcSEcCtD
Fosinopril—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000334	CcSEcCtD
Fosinopril—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000333	CcSEcCtD
Fosinopril—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000305	0.000332	CcSEcCtD
Fosinopril—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000332	CcSEcCtD
Fosinopril—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000332	CcSEcCtD
Fosinopril—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000331	CcSEcCtD
Fosinopril—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000304	0.000331	CcSEcCtD
Fosinopril—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000304	0.000331	CcSEcCtD
Fosinopril—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00033	CcSEcCtD
Fosinopril—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00033	CcSEcCtD
Fosinopril—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000302	0.000328	CcSEcCtD
Fosinopril—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000302	0.000328	CcSEcCtD
Fosinopril—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000328	CcSEcCtD
Fosinopril—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000328	CcSEcCtD
Fosinopril—Rash—Vincristine—peripheral nervous system neoplasm	0.000299	0.000326	CcSEcCtD
Fosinopril—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000299	0.000325	CcSEcCtD
Fosinopril—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000325	CcSEcCtD
Fosinopril—Headache—Vincristine—peripheral nervous system neoplasm	0.000297	0.000323	CcSEcCtD
Fosinopril—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000321	CcSEcCtD
Fosinopril—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000319	CcSEcCtD
Fosinopril—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.000318	CcSEcCtD
Fosinopril—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000318	CcSEcCtD
Fosinopril—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000317	CcSEcCtD
Fosinopril—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000312	CcSEcCtD
Fosinopril—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000312	CcSEcCtD
Fosinopril—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000311	CcSEcCtD
Fosinopril—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000283	0.000308	CcSEcCtD
Fosinopril—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000308	CcSEcCtD
Fosinopril—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000307	CcSEcCtD
Fosinopril—Nausea—Vincristine—peripheral nervous system neoplasm	0.000282	0.000307	CcSEcCtD
Fosinopril—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000306	CcSEcCtD
Fosinopril—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000306	CcSEcCtD
Fosinopril—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000305	CcSEcCtD
Fosinopril—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000305	CcSEcCtD
Fosinopril—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000304	CcSEcCtD
Fosinopril—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000303	CcSEcCtD
Fosinopril—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000301	CcSEcCtD
Fosinopril—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000276	0.0003	CcSEcCtD
Fosinopril—Chills—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000296	CcSEcCtD
Fosinopril—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000272	0.000296	CcSEcCtD
Fosinopril—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000295	CcSEcCtD
Fosinopril—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000294	CcSEcCtD
Fosinopril—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000267	0.00029	CcSEcCtD
Fosinopril—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000289	CcSEcCtD
Fosinopril—Rash—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000288	CcSEcCtD
Fosinopril—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000264	0.000288	CcSEcCtD
Fosinopril—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000263	0.000286	CcSEcCtD
Fosinopril—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000285	CcSEcCtD
Fosinopril—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000283	CcSEcCtD
Fosinopril—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000283	CcSEcCtD
Fosinopril—Tension—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000282	CcSEcCtD
Fosinopril—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000281	CcSEcCtD
Fosinopril—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000279	CcSEcCtD
Fosinopril—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000254	0.000277	CcSEcCtD
Fosinopril—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000276	CcSEcCtD
Fosinopril—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000274	CcSEcCtD
Fosinopril—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000273	CcSEcCtD
Fosinopril—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000271	CcSEcCtD
Fosinopril—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000271	CcSEcCtD
Fosinopril—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000267	CcSEcCtD
Fosinopril—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000244	0.000266	CcSEcCtD
Fosinopril—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000266	CcSEcCtD
Fosinopril—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000264	CcSEcCtD
Fosinopril—Rash—Etoposide—peripheral nervous system neoplasm	0.000242	0.000264	CcSEcCtD
Fosinopril—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000242	0.000264	CcSEcCtD
Fosinopril—Headache—Etoposide—peripheral nervous system neoplasm	0.000241	0.000262	CcSEcCtD
Fosinopril—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000262	CcSEcCtD
Fosinopril—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000261	CcSEcCtD
Fosinopril—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.00026	CcSEcCtD
Fosinopril—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000259	CcSEcCtD
Fosinopril—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000258	CcSEcCtD
Fosinopril—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000258	CcSEcCtD
Fosinopril—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000258	CcSEcCtD
Fosinopril—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000257	CcSEcCtD
Fosinopril—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000256	CcSEcCtD
Fosinopril—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000254	CcSEcCtD
Fosinopril—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000253	CcSEcCtD
Fosinopril—Cough—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000251	CcSEcCtD
Fosinopril—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000251	CcSEcCtD
Fosinopril—Nausea—Etoposide—peripheral nervous system neoplasm	0.000228	0.000248	CcSEcCtD
Fosinopril—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000248	CcSEcCtD
Fosinopril—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000247	CcSEcCtD
Fosinopril—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000246	CcSEcCtD
Fosinopril—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000245	CcSEcCtD
Fosinopril—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000245	CcSEcCtD
Fosinopril—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000245	CcSEcCtD
Fosinopril—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000244	CcSEcCtD
Fosinopril—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000242	CcSEcCtD
Fosinopril—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00024	CcSEcCtD
Fosinopril—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000239	CcSEcCtD
Fosinopril—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.000239	CcSEcCtD
Fosinopril—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000238	CcSEcCtD
Fosinopril—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000238	CcSEcCtD
Fosinopril—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000236	CcSEcCtD
Fosinopril—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000235	CcSEcCtD
Fosinopril—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000234	CcSEcCtD
Fosinopril—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000234	CcSEcCtD
Fosinopril—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000234	CcSEcCtD
Fosinopril—Infection—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000233	CcSEcCtD
Fosinopril—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000232	CcSEcCtD
Fosinopril—Shock—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000231	CcSEcCtD
Fosinopril—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00023	CcSEcCtD
Fosinopril—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.00023	CcSEcCtD
Fosinopril—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000229	CcSEcCtD
Fosinopril—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000227	CcSEcCtD
Fosinopril—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000226	CcSEcCtD
Fosinopril—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000226	CcSEcCtD
Fosinopril—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000226	CcSEcCtD
Fosinopril—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000224	CcSEcCtD
Fosinopril—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000224	CcSEcCtD
Fosinopril—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000221	CcSEcCtD
Fosinopril—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000219	CcSEcCtD
Fosinopril—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000219	CcSEcCtD
Fosinopril—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000217	CcSEcCtD
Fosinopril—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000217	CcSEcCtD
Fosinopril—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000216	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000214	CcSEcCtD
Fosinopril—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000213	CcSEcCtD
Fosinopril—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000212	CcSEcCtD
Fosinopril—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000212	CcSEcCtD
Fosinopril—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000212	CcSEcCtD
Fosinopril—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000211	CcSEcCtD
Fosinopril—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00021	CcSEcCtD
Fosinopril—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000209	CcSEcCtD
Fosinopril—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000208	CcSEcCtD
Fosinopril—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000207	CcSEcCtD
Fosinopril—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000206	CcSEcCtD
Fosinopril—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000204	CcSEcCtD
Fosinopril—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000203	CcSEcCtD
Fosinopril—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000202	CcSEcCtD
Fosinopril—Pain—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000201	CcSEcCtD
Fosinopril—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000201	CcSEcCtD
Fosinopril—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000198	CcSEcCtD
Fosinopril—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000196	CcSEcCtD
Fosinopril—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000195	CcSEcCtD
Fosinopril—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000193	CcSEcCtD
Fosinopril—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000193	CcSEcCtD
Fosinopril—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000193	CcSEcCtD
Fosinopril—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000192	CcSEcCtD
Fosinopril—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000191	CcSEcCtD
Fosinopril—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000189	CcSEcCtD
Fosinopril—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000187	CcSEcCtD
Fosinopril—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000186	CcSEcCtD
Fosinopril—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000186	CcSEcCtD
Fosinopril—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000186	CcSEcCtD
Fosinopril—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000185	CcSEcCtD
Fosinopril—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000185	CcSEcCtD
Fosinopril—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000179	CcSEcCtD
Fosinopril—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000177	CcSEcCtD
Fosinopril—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000173	CcSEcCtD
Fosinopril—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Fosinopril—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Fosinopril—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000172	CcSEcCtD
Fosinopril—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000168	CcSEcCtD
Fosinopril—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000166	CcSEcCtD
Fosinopril—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000147	0.00016	CcSEcCtD
Fosinopril—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.00016	CcSEcCtD
Fosinopril—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000156	CcSEcCtD
Fosinopril—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000155	CcSEcCtD
Fosinopril—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000153	CcSEcCtD
Fosinopril—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000149	CcSEcCtD
Fosinopril—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Fosinopril—Rash—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Fosinopril—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000148	CcSEcCtD
Fosinopril—Headache—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000147	CcSEcCtD
Fosinopril—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000143	CcSEcCtD
Fosinopril—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000139	CcSEcCtD
Fosinopril—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000138	CcSEcCtD
Fosinopril—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Fosinopril—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000137	CcSEcCtD
Fosinopril—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000136	CcSEcCtD
Fosinopril—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000129	CcSEcCtD
